Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
ALNLF.PA Stock Summary
Top 10 Correlated ETFs
ALNLF.PA
In the News
ALNLF.PA Financial details
Company Rating
Sell
Market Cap
8.96M
Income
-3.59M
Revenue
24.43M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
18
Optionable
No
Shortable
Yes
Earnings
-
P/E
-29.82
Forward P/E
-
PEG
-21.98
P/S
0.78
P/B
2.27
P/C
-
P/FCF
-8.88
Quick Ratio
1.47
Current Ratio
3.57
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.04
EPS next Y
-
EPS next Q
-
EPS this Y
-85.64%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-23.04%
Revenue last 5Y
9.08%
Revenue Q/Q
-21.27%
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-3%
ROE
-8%
ROC
0.01%
Gross Margin
32%
Oper. Margin
1%
Profit Margin
-2%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.0541-0.1282
52W High
-
52W Low
-
RSI
59
Rel Volume
0.67
Avg Volume
223.79K
Volume
149.18K
Perf Week
-4.86%
Perf Month
39.46%
Perf Quarter
29.99%
Perf Half Y
44.26%
-
-
-
-
Beta
2.439
-
-
Volatility
0%, 0.01%
Prev Close
-2.11%
Price
0.088
Change
2.44%
ALNLF.PA Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.18 | 0.15 | 0.2 | 0.14 | 0 | |
Net income per share | -0.02 | -0.01 | -0.01 | -0.04 | 0 | |
Operating cash flow per share | -0.01 | 0.01 | 0 | -0.01 | 0 | |
Free cash flow per share | -0.02 | 0 | -0.02 | -0.01 | 0 | |
Cash per share | 0.02 | 0.06 | 0.03 | 0.01 | 0 | |
Book value per share | 0.05 | 0.04 | 0.08 | 0.05 | 0 | |
Tangible book value per share | 0.02 | 0.02 | 0.07 | 0.01 | 0 | |
Share holders equity per share | 0.05 | 0.04 | 0.08 | 0.05 | 0 | |
Interest debt per share | 0.03 | 0.06 | 0.05 | 0.02 | 0 | |
Market cap | 7.54M | 23.34M | 16.13M | 6.78M | 0 | |
Enterprise value | 7.82M | 23.28M | 17M | 7.44M | 0 | |
P/E ratio | -8.1 | -45.2 | -53.06 | -1.87 | 0 | |
Price to sales ratio | 0.91 | 2.98 | 1.5 | 0.51 | 0 | |
POCF ratio | -20.35 | 64.4 | -170.88 | -7.88 | 0 | |
PFCF ratio | -9.07 | -255.51 | -17.18 | -5.54 | 0 | |
P/B Ratio | 3.05 | 10.92 | 3.95 | 1.41 | 0 | |
PTB ratio | 3.05 | 10.92 | 3.95 | 1.41 | 0 | |
EV to sales | 0.94 | 2.97 | 1.59 | 0.56 | 0 | |
Enterprise value over EBITDA | -60.95 | 104.19 | 46.24 | -14.46 | 0 | |
EV to operating cash flow | -21.1 | 64.24 | -180.11 | -8.65 | 0 | |
EV to free cash flow | -9.4 | -254.88 | -18.1 | -6.08 | 0 | |
Earnings yield | -0.12 | -0.02 | -0.02 | -0.53 | 0 | |
Free cash flow yield | -0.11 | 0 | -0.06 | -0.18 | 0 | |
Debt to equity | 0.48 | 1.53 | 0.66 | 0.42 | 0 | |
Debt to assets | 0.23 | 0.46 | 0.32 | 0.24 | 0 | |
Net debt to EBITDA | -2.16 | -0.26 | 2.37 | -1.28 | 0 | |
Current ratio | 1.82 | 2.41 | 2.62 | 1.96 | 0 | |
Interest coverage | -9.97 | -7.24 | -6.1 | -19.26 | 0 | |
Income quality | 0.4 | -0.7 | 0.31 | 0.24 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.01 | 0.02 | 0.01 | 0 | 0 | |
Research and developement to revenue | 0.01 | 0 | 0.01 | 0 | 0 | |
Intangibles to total assets | 0.28 | 0.18 | 0.07 | 0.42 | 0 | |
Capex to operating cash flow | 1.24 | -1.25 | 8.95 | 0.42 | 0 | |
Capex to revenue | -0.06 | -0.06 | -0.08 | -0.03 | 0 | |
Capex to depreciation | -0.71 | -0.66 | -1.31 | -0.65 | 0 | |
Stock based compensation to revenue | -0.16 | -0.18 | -0.1 | 0 | 0 | |
Graham number | 0.15 | 0.1 | 0.1 | 0.21 | 0 | |
ROIC | -0.24 | -0.11 | -0.03 | -0.16 | 0 | |
Return on tangible assets | -0.25 | -0.09 | -0.04 | -0.74 | 0 | |
Graham Net | -0.01 | -0.01 | -0.02 | 0 | 0 | |
Working capital | 1.53M | 3.22M | 2.52M | 2.13M | 0 | |
Tangible asset value | 1.01M | 879.71K | 3.49M | 1.36M | 0 | |
Net current asset value | 643.73K | 543.5K | -201.78K | 831.28K | 0 | |
Invested capital | 0.48 | 1.53 | 0.66 | 0.42 | 0 | |
Average receivables | 606.17K | 1.14M | 1.14M | 1.58M | 972.08K | |
Average payables | 377.56K | 782.54K | 824.78K | 762.86K | 343.67K | |
Average inventory | 283.39K | 545.47K | 723.24K | 889.4K | 428.55K | |
Days sales outstanding | 53.2 | 49.65 | 41.15 | 53.26 | 0 | |
Days payables outstanding | 32.49 | 40.45 | 27.6 | 17.56 | 0 | |
Days of inventory on hand | 24.4 | 26.17 | 30.35 | 21.89 | 0 | |
Receivables turnover | 6.86 | 7.35 | 8.87 | 6.85 | 0 | |
Payables turnover | 11.23 | 9.02 | 13.22 | 20.79 | 0 | |
Inventory turnover | 14.96 | 13.95 | 12.03 | 16.67 | 0 | |
ROE | -0.38 | -0.24 | -0.07 | -0.75 | 0 | |
Capex per share | -0.01 | -0.01 | -0.02 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2021-12-31 | 2022-06-30 | 2022-12-31 | 2023-06-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.11 | 0.13 | 0.07 | 0 | 0 | |
Net income per share | 0 | -0.01 | -0.03 | 0 | 0 | |
Operating cash flow per share | 0 | -0.01 | 0 | 0 | 0 | |
Free cash flow per share | -0.01 | -0.01 | 0 | 0 | 0 | |
Cash per share | 0.04 | 0.01 | 0.01 | 0 | 0 | |
Book value per share | 0.04 | 0.03 | 0.05 | 0 | 0 | |
Tangible book value per share | 0.02 | 0.01 | 0.01 | 0 | 0 | |
Share holders equity per share | 0.04 | 0.03 | 0.05 | 0 | 0 | |
Interest debt per share | 0.05 | 0.04 | 0.02 | 0 | 0 | |
Market cap | 16.13M | 6.86M | 6.78M | 0 | 0 | |
Enterprise value | 17M | 8.49M | 7.44M | 762.72K | 0 | |
P/E ratio | 108.91 | -2.6 | -0.57 | 0 | 0 | |
Price to sales ratio | 2.78 | 1.04 | 1.01 | 0 | 0 | |
POCF ratio | 795.56 | -11.74 | -24.53 | 0 | 0 | |
PFCF ratio | -29.31 | -8.81 | -15.23 | 0 | 0 | |
P/B Ratio | 7.24 | 4.37 | 1.41 | 0 | 0 | |
PTB ratio | 7.24 | 4.37 | 1.41 | 0 | 0 | |
EV to sales | 2.93 | 1.29 | 1.11 | 0 | 0 | |
Enterprise value over EBITDA | 53.5 | -23.68 | -36.93 | 0 | 0 | |
EV to operating cash flow | 838.16 | -14.53 | -26.91 | 0 | 0 | |
EV to free cash flow | -30.88 | -10.9 | -16.7 | 0 | 0 | |
Earnings yield | 0 | -0.1 | -0.44 | 0 | 0 | |
Free cash flow yield | -0.03 | -0.11 | -0.07 | 0 | 0 | |
Debt to equity | 1.21 | 1.47 | 0.42 | 0.37 | 0 | |
Debt to assets | 0.43 | 0.4 | 0.24 | 0.22 | 0 | |
Net debt to EBITDA | 2.72 | -4.55 | -3.26 | 0 | 0 | |
Current ratio | 2.2 | 1.62 | 1.96 | 2.5 | 0 | |
Interest coverage | 0.71 | -19.18 | -11.4 | 0 | 0 | |
Income quality | 0.55 | 0.89 | 0.09 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.09 | 0.12 | 0.04 | 0 | 0 | |
Research and developement to revenue | 0 | 0.01 | 0 | 0 | 0 | |
Intangibles to total assets | 0.18 | 0.18 | 0.42 | 0.44 | 0 | |
Capex to operating cash flow | -28.14 | 0.33 | 0.61 | 0 | 0 | |
Capex to revenue | -0.1 | -0.03 | -0.03 | 0 | 0 | |
Capex to depreciation | -1.94 | -0.65 | -0.83 | 0 | 0 | |
Stock based compensation to revenue | -0.1 | -0.09 | -0.06 | 0 | 0 | |
Graham number | 0.03 | 0.09 | 0.19 | 0 | 0 | |
ROIC | 0 | -0.18 | -0.06 | 0 | 0 | |
Return on tangible assets | 0.01 | -0.14 | -0.61 | 0 | 0 | |
Graham Net | -0.02 | -0.03 | 0 | 0 | 0 | |
Working capital | 2.42M | 1.58M | 2.13M | 2.33M | 0 | |
Tangible asset value | 1.11M | 548.4K | 1.36M | 1.11M | 0 | |
Net current asset value | 453.87K | -38.89K | 831.28K | 741.48K | 0 | |
Invested capital | 1.21 | 1.47 | 0.42 | 0.37 | 0 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 17.62 | 23.23 | 25.99 | 0 | 0 | |
Days payables outstanding | 8.35 | 14.72 | 9.06 | 0 | 0 | |
Days of inventory on hand | 15.81 | 16.28 | 11.3 | 0 | 0 | |
Receivables turnover | 5.11 | 3.87 | 3.46 | 0 | 0 | |
Payables turnover | 10.77 | 6.11 | 9.93 | 0 | 0 | |
Inventory turnover | 5.69 | 5.53 | 7.96 | 0 | 0 | |
ROE | 0.02 | -0.42 | -0.61 | 0 | 0 | |
Capex per share | -0.01 | 0 | 0 | 0 | 0 |
ALNLF.PA Frequently Asked Questions
What is Neolife SA stock symbol ?
Neolife SA is a FR stock and trading under the symbol ALNLF.PA
What is Neolife SA stock quote today ?
Neolife SA stock price is $0.088 today.
Is Neolife SA stock public?
Yes, Neolife SA is a publicly traded company.